Blind People Offered Hope of Seeing Again After Stem Cell Breakthrough Remakes Retinal Blood Vessels
When injected into mice with retinal disease, the special retinal blood cells integrated into the damaged tissue to ...
O'Shaughnessy Ventures LLC (OSV), an investment firm that empowers creators, has awarded an O'Shaughnessy Fellowship to Liam Aranda-Michel, a bioengineering researcher based in Cambridge, ...
The U.S. Active Wound Care Market is projected to grow from USD 0.54 Billion in 2025 to USD 0.81 Billion by 2035, while ...
Study HighlightsP.R.O.O.F study complete, marking an important catalyst. Conexeu has completed its P.R.O.O.F (Performance and Regeneration ...
Russell 1000 classification changes, FDA PMA approval, cardiovascular device portfolio, global operations, aortic ...
Indian American pioneer in systems glycobiology gets the highest rank in the State University of New York system.
If you're a woman newly diagnosed with breast cancer, treatment can feel ... well, scary. Will chemotherapy work? Or will it ...
Scientists at a NY university say they can bring back the near extinct American chestnut tree, wiped out a century ago, ...
Researchers from Duke University in the US found that the lab-grown cells helped to regenerate blood vessels and restore ...
An analytical guide to cellular optimization, epigenetic switches, and the daily disciplines that preserve youth from the ...
Morning Overview on MSN
The FDA approved a lower-dose contrast agent to cut patients’ exposure during MRI scans
Patients who need repeated MRI scans with contrast dye could soon receive a fraction of the gadolinium they currently get.
Ischemic heart disease (IHD), also known as coronary artery disease, is a leading cause of death and morbidity in Western ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results